Xcout Intel
Vantis Vascular, Inc.
Vantis Vascular, Inc. is a pioneering medical technology company headquartered in San Jose, California, founded by physicians to develop advanced vascular intervention solutions such as the CrossFAST performance system.
Subscribe to see Vantis Vascular, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vantis Vascular, Inc. at a glance
Vantis Vascular, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $18.6M in June 2026. Xcout tracks 8 named people at Vantis Vascular, Inc., including Frank Saltiel (Executive Officer).
Vantis Vascular, Inc. leadership
- Frank SaltielExecutive Officer
- Gary McCordExecutive Officer
- Jason TurnerExecutive Officer
- Marc MonahanExecutive Officer
- Mike MirizziExecutive Officer
- Phillip TorrenceSecretary
2 more named people on record for Vantis Vascular, Inc., with roles, board committees and tenure — see the full roster →
Vantis Vascular, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $18.6M | — | |
| Series B | $10M | — | |
| SEC Form D filing | $14.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Vantis Vascular, Inc. competitors
A few of Vantis Vascular, Inc.'s closest competitors — see the full list of competitors and alternatives →
Integrated Vascular Systems Inc. is headquartered in Sunnyvale, California, and operates within the vascular medical device and systems market.
Cardiva Medical, Inc. is a privately held medical device manufacturer headquartered in Santa Clara, California, specializing in vascular closure and related healthcare products.
Embolx, Inc. is a medical equipment manufacturing company located in Sunnyvale, California, recognized as a leader in advanced microcatheter technology for targeted embolization procedures.
Xeltis is a medical technology company that develops bioresorbable cardiovascular implants, such as artificial blood vessels and valves. Utilizing its proprietary Restorex technology, the company's products are designed to be gradually replaced by the patient's own living tissue to treat life-threatening conditions and improve vascular surgery outcomes.
VVT Med Inc. develops minimally invasive, catheter-based medical devices designed for the treatment of various venous pathologies, including varicose veins. The company's proprietary products, such as ScleroSafe and V-Block, utilize mechanochemical technology to provide precise, non-thermal, and in-office vein closure treatments for patients.
Scientia Vascular, Inc. is an active medical technology company backed by growth financing that develops specialized vascular access products and medical devices.
Get Vantis Vascular, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Vantis Vascular, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access